PT - JOURNAL ARTICLE ED - , TI - â–¼Moclobemide for depression AID - 10.1136/dtb.1994.3216 DP - 1994 Jan 01 TA - Drug and Therapeutics Bulletin PG - 6--8 VI - 32 IP - 1 4099 - http://dtb.bmj.com/content/32/1/6.short 4100 - http://dtb.bmj.com/content/32/1/6.full SO - Drug Ther Bull1994 Jan 01; 32 AB - Relevant BNF section: 4.3.2Moclobemide (Manerix - Roche), the first of a new class of antidepressant drugs, was launched in the UK last year. It is a reversible inhibitor of monoamine oxidase A, which the manufacturer claims is a "first line treatment for major depression". Is this claim justified?